glp-1 kidney pain receptor agonists in patients with chronic disease and either overweight or obesity Real-World Evidence for GLP-1 Receptor
Description
Diabetes Obes Metab 25(1):5667 Rosenstock J, Wysham C, Frias JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
These drugs are especially popular among Americans, where obesity rates are high
Similarly, those with a history of restrictive eating may find that appetite suppression reinforces unhealthy patterns
What if you want to eat a donut, still get GLP-1 activation, and keep your anatomy intact
Researchers have been interested in the nutritional benefits of cinnamon for a long time
At NexGen, we go beyond medication by providing ongoing support through in-person coaching and telehealth services
